Rock Springs Capital Management as of Dec. 31, 2013
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 69 positions in its portfolio as reported in the December 2013 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Gilead Sciences (GILD) | 7.7 | $21M | 285k | 75.15 | |
Health Care SPDR (XLV) | 7.3 | $21M | 370k | 55.44 | |
Biogen Idec (BIIB) | 5.3 | $15M | 53k | 279.75 | |
Abbvie (ABBV) | 4.2 | $12M | 225k | 52.81 | |
Celgene Corporation | 3.7 | $11M | 62k | 168.97 | |
McKesson Corporation (MCK) | 3.6 | $10M | 63k | 161.40 | |
Thoratec Corporation | 3.6 | $10M | 275k | 36.60 | |
Bristol Myers Squibb (BMY) | 3.4 | $9.6M | 181k | 53.15 | |
Amgen (AMGN) | 3.2 | $9.0M | 79k | 114.16 | |
Agilent Technologies Inc C ommon (A) | 2.7 | $7.6M | 133k | 57.19 | |
Thermo Fisher Scientific (TMO) | 2.7 | $7.5M | 68k | 111.35 | |
UnitedHealth (UNH) | 2.7 | $7.5M | 100k | 75.30 | |
Gentium S.p.A. | 2.4 | $6.8M | 120k | 57.10 | |
Alexion Pharmaceuticals | 2.4 | $6.8M | 51k | 133.06 | |
Intuitive Surgical (ISRG) | 2.4 | $6.7M | 18k | 384.06 | |
Illumina (ILMN) | 2.2 | $6.1M | 55k | 110.62 | |
Valeant Pharmaceuticals Int | 2.0 | $5.5M | 47k | 117.40 | |
Team Health Holdings | 1.9 | $5.4M | 118k | 45.55 | |
Cardinal Health (CAH) | 1.5 | $4.3M | 64k | 66.81 | |
Aetna | 1.5 | $4.3M | 62k | 68.59 | |
Actavis | 1.5 | $4.1M | 25k | 168.00 | |
CVS Caremark Corporation (CVS) | 1.4 | $3.9M | 55k | 71.58 | |
Walgreen Company | 1.3 | $3.7M | 64k | 57.44 | |
Humana (HUM) | 1.2 | $3.4M | 33k | 103.21 | |
Puma Biotechnology (PBYI) | 1.2 | $3.3M | 32k | 103.52 | |
HeartWare International | 1.1 | $3.1M | 33k | 93.95 | |
Orexigen Therapeutics | 1.1 | $3.0M | 525k | 5.63 | |
Pacira Pharmaceuticals (PCRX) | 1.0 | $2.9M | 51k | 57.49 | |
Edwards Lifesciences (EW) | 1.0 | $2.8M | 43k | 65.76 | |
Aegerion Pharmaceuticals | 1.0 | $2.8M | 39k | 70.96 | |
Hca Holdings (HCA) | 1.0 | $2.8M | 58k | 47.71 | |
athenahealth | 0.9 | $2.6M | 20k | 134.51 | |
Tornier Nv | 0.9 | $2.4M | 130k | 18.79 | |
Universal Health Services (UHS) | 0.8 | $2.3M | 29k | 81.26 | |
Theravance | 0.8 | $2.2M | 63k | 35.65 | |
Covance | 0.8 | $2.2M | 26k | 88.08 | |
FEI Company | 0.8 | $2.2M | 25k | 89.35 | |
Incyte Corporation (INCY) | 0.8 | $2.1M | 42k | 50.63 | |
Auxilium Pharmaceuticals | 0.7 | $2.1M | 100k | 20.74 | |
Cooper Companies | 0.7 | $2.0M | 17k | 123.82 | |
Forest Laboratories | 0.7 | $2.0M | 34k | 60.03 | |
Pharmacyclics | 0.7 | $2.0M | 19k | 105.78 | |
Cerner Corporation | 0.7 | $1.9M | 34k | 55.74 | |
InterMune | 0.7 | $1.8M | 125k | 14.73 | |
Mednax (MD) | 0.6 | $1.7M | 32k | 53.38 | |
Jazz Pharmaceuticals (JAZZ) | 0.6 | $1.6M | 13k | 126.54 | |
Tesaro | 0.6 | $1.6M | 58k | 28.24 | |
AmerisourceBergen (COR) | 0.6 | $1.6M | 23k | 70.31 | |
Mylan | 0.6 | $1.6M | 37k | 43.40 | |
Advisory Board Company | 0.6 | $1.6M | 25k | 63.67 | |
CHINA CORD Blood Corp | 0.5 | $1.5M | 375k | 4.01 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.5 | $1.5M | 20k | 74.30 | |
Infinity Pharmaceuticals (INFIQ) | 0.5 | $1.3M | 96k | 13.81 | |
WuXi PharmaTech | 0.5 | $1.3M | 34k | 38.39 | |
Medicines Company | 0.5 | $1.3M | 33k | 38.62 | |
Cubist Pharmaceuticals | 0.4 | $1.2M | 18k | 68.86 | |
WellCare Health Plans | 0.4 | $1.2M | 17k | 70.42 | |
Novavax | 0.4 | $1.1M | 220k | 5.12 | |
Intercept Pharmaceuticals In | 0.4 | $1.1M | 17k | 68.30 | |
XenoPort | 0.4 | $1.0M | 175k | 5.75 | |
AVANIR Pharmaceuticals | 0.4 | $1.0M | 300k | 3.36 | |
Air Methods Corporation | 0.3 | $992k | 17k | 58.35 | |
Alkermes (ALKS) | 0.3 | $945k | 23k | 40.65 | |
Exelixis (EXEL) | 0.3 | $920k | 150k | 6.13 | |
Cadence Pharmaceuticals | 0.3 | $810k | 90k | 9.05 | |
ACADIA Pharmaceuticals (ACAD) | 0.3 | $785k | 31k | 24.99 | |
Nektar Therapeutics (NKTR) | 0.3 | $738k | 65k | 11.35 | |
EnteroMedics | 0.3 | $714k | 350k | 2.04 | |
Ophthotech | 0.2 | $641k | 20k | 32.37 |